Recruiting NCT05770661
China Children Eye Study
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Axial Length, Myopia, Child Development. Basic parameters: 3 years — 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- China
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
China Nine Provinces Children Eye Study
Overview
The primary objective of this multi-center, observational study is to establish the reference ranges of axial length in Chinese children and adolescents. 30,000 children aged 3-18 years were examined with cycloplegia to collect their ocular parameters and were all followed up for three years with annual visits.
Primary outcome measures
- Axial length [Time frame: 2023-2026]
Secondary outcome measures (1)
- Axial length elongation [Time frame: 2023-2026]
Eligibility criteria
Inclusion criteria
- Aged 3 to 18 years
- Have been lived in the research areas for at least one year, and will not move to other places in the following two years
- Parents or guardians sign an informed consent form, and children over 6 years old need oral consent to participate
Exclusion criteria
- Mental diseases, unable to cooperate to complete the eye assessment
- Ophthalmic diseases, inability to cooperate to complete the inspection
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Observational model
- Cohort
Study locations
China · 2 centers
- Shanghai Eye Disease Prevention & Treatment Center — Shanghai
- Shanghai Eye Disease Prevention and Treatment Center — Shanghai
Identifiers
NCT: NCT05770661 · NO.CALS20220101